Enveric Biosciences annual free cash flow
2021
2022
2023
Enveric Biosciences Free Cash Flow (FCF) History (ENVB)
Enveric Biosciences reported −$14.1M in free cash flow for fiscal 2023, an increase of $3.6M from the previous fiscal year.
View full Enveric Biosciences company overviewEnveric Biosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$14.1M | $3.6M | — | — |
| 2022 | 2022-12-31 | −$17.7M | −$6.1M | — | — |
| 2021 | 2021-12-31 | −$11.6M | — | — | — |
Enveric Biosciences quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | −$1.8M | $1.7M | — | — |
| Q3 2023 | 2023-09-30 | −$2.7M | $1.8M | — | — |
| Q2 2023 | 2023-06-30 | −$4.5M | $173,149 | — | — |
| Q1 2023 | 2023-03-31 | −$5.1M | −$87,730 | — | — |
| Q4 2022 | 2022-12-31 | −$3.5M | — | — | — |
| Q3 2022 | 2022-09-30 | −$4.6M | — | — | — |
| Q2 2022 | 2022-06-30 | −$4.6M | — | — | — |
| Q1 2022 | 2022-03-31 | −$5.1M | — | — | — |
Enveric Biosciences free cash flow growth trends
Enveric Biosciences's latest reported quarter, Q4 2023, generated −$1.8M in free cash flow, an increase of $1.7M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Enveric Biosciences filings at SEC.gov ↗